A Successful Case of Controlling the Multiple Distant Metastasis of Pancreatic G2 NET with Local Therapy Combined with Systemic Pharmacotherapy Abstract #1670

Introduction: Several systemic pharmacotherapies could be applied to multiple metastatic pancreatic neuroendocrine tumor (PNET). However, we have not determined how to coordinate ‘local’ therapy such as salvage surgery and transarterial chemoembolization with systemic pharmacotherapies for these multiple metastatic PNET.
Aim(s): To discuss the desirable combination of local therapy with systemic pharmacotherapy.
Materials and methods: We report a successful case of controlling multiple liver metastases with lymphnode metastases of Grade2 PNET treated with combination of local and systemic therapy.
Conference: 14th Annual ENETS conference (2017)
Category: Clinical cases/reports
Presenting Author: Yuichiro Uchida

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1144 Aggressive Multi-Modality Treatment of Pancreatic Neuroendocrine Tumors (pNETs): Outcomes in Patients with Advanced Disease
Introduction: pNETs carry the worst prognosis of all NETs, particularly when hepatic metastasis are present. We try to actively treat all patients referred.
Conference: 12th Annual ENETS Conference (2015)
Category: Surgical treatment
Presenting Author: Damian Mayo
Authors: Mayo D, Armstrong T, Cave J, Nolan L, ...
#835 Surgical Management of the Patients with Liver Metastases of Pancreatic Neuroendocrine Tumors
Introduction: Most pancreatic neuroendocrine tumors (PNET) grow slowly but around 60% of the patients have distant metastases. Although new drugs have recently emerged, surgical resection is still one of the key modalities for curing the tumor.
Conference: 11th Annual ENETS Conference (2014)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui
#1888 Selective Transarterial Embolization of Gastro-Entero Pancreatic (GEP) Neuroendocrine Tumors (NET) with Advanced Locoregional Disease and/or Liver Metastases
Introduction: Selective transarterial embolization(TAE) and chemoembolization(TACE),are alternative options to systemic therapies in patients with GEP-NET G1/G2 with advanced locoregional disease and/or unresectable liver metastases
Conference: 14th Annual ENETS conference (2017)
Category: PRRT-Ablative therapies- Endoscopic treatment, surgical treatment
Presenting Author: Dr Concepcion Blanco
Keywords: TACE, TAE, GEP-NET
#1600 Should Surgery Be Conducted for Small Nonfunctioning Pancreatic Neuroendocrine Tumors: A Systemic Review
Introduction: Researches showed controversial results regarding whether surgery should be conducted for nonfunctioning pancreatic neuroendocrine tumors (PNETS) smaller than 2 cm. Both the ENETS and NCCN guidelines recommended observation for selected cases, while none of them pointed out which cases should be chosen.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Jingfei Guo
Authors: Guo J, Zhao J, Bi X, Li Z, ...
Keywords: PNETS, 2 cm, surgery
#766 Aggressive Surgery for Pancreatic Neuroendocrine Tumors
Introduction: The role of surgery for advanced pancreatic neuroendocrine tumor (pNET) requiring extended resections is not well-defined.
Conference: 10th Annual ENETS Conference (2013)
Category: Biomarkers
Presenting Author: Nadia Russolillo
Close
Notice
Important Notice:

In preparation of the upcoming ENETS Barcelona 2018 Annual Conference, we have discovered in the world wide web at least one professional entity suggestive of possessing an ENETS mandate for conference registrations. Therefore, we must inform you that 100% of all conference participants are registered through ENETS official website www.enets.org and http://enetsconference.org/. There are no further options to validly register for Barcelona 2018 (or for any other ENETS event).

Please stay away from fraudulent scams abusing the ENETS acronym to register – and charge you above official ENETS conference fees! Such entities, against whom ENETS presses criminal charges, are neither authorized, nor commissioned nor instructed by ENETS to make such representations.